Skip to main content

Table 3 Uptake of indicators of continuous care and other characteristics of accessibility of care for people living with HIV on ART according to HIV-acquisition risk

From: Measuring the uptake of continuous care among people living with HIV receiving antiretroviral therapy and social determinants of the uptake of continuous care in the southwest of China: a cross-sectional study

 

Total (n = 702)

HIV-acquisition risk category

p value

Heterosexuals (n = 239)

MSM (n = 231)

PWID (n = 232)

Indicators of continuous care (%)

 Adequate routine visit

82.9

77.0

87.9

84.1

0.006

 Adequate routine test

81.9

80.8

85.7

79.3

0.171

 Adequate CD4 testing

80.6

80.8

87.0

74.1

0.002

 Adequate viral load testing

15.8

15.9

23.8

7.8

 < 0.001

 Mental health assessment

15.0

15.9

23.8

7.8

 < 0.001

 Mental health counselling

30.8

20.9

31.6

40.1

 < 0.001

 BMD measurement

36.5

40.2

46.3

22.8

 < 0.001

 CKD risk evaluation

84.8

91.6

94.4

68.1

 < 0.001

 CVD risk monitoring

84.6

93.7

89.2

70.7

 < 0.001

 ECG

71.1

74.5

71.0

67.7

0.265

 TB screening

93.3

98.7

95.7

85.3

 < 0.001

 HBV serological test

63.5

62.8

73.6

54.3

 < 0.001

 HCV serological test

70.4

59.4

68.4

83.6

 < 0.001

 Syphilis serological test

51.0

53.1

60.6

39.2

 < 0.001

Other characteristics of accessibility of care

 Chronic comorbidities (%)

39.2

18.0

13.0

87.1

 < 0.001

 Distance to HIV facilities, (kilometers)

10.0 (5.0,30.0)

11.0 (7.0,40.0)

10.0 (5.0, 20.0)

10.0 (5.0, 30.0)

0.005

 Travel time, (hour)

0.7 (0.5,1.0)

1.0 (0.5,1.5)

0.5 (0.5,1.0)

0.7 (0.3,1.0)

 < 0.001

 Transportation fee, (yuan)

6.0 (2.2,20.0)

6.0 (2.0,23.5)

10.0 (3.0,20.0)

5.0 (2.0,20.0)

0.310

 Waiting time for getting medicine, (hour)

1.0 (0.7,2.0)

1.5 (1.0, 2.0)

1.5 (1.0, 2.0)

1.0 (0.5,2.0)

 < 0.001

 ART duration, (years)

3.7 (2.1, 4.7)

3.8 (2.2, 4.6)

3.0 (1.6, 4.4)

4.1 (2.7, 4.7)

 < 0.001

  1. Data are column percentage or median (IQR). MSM men who have sex with men, PWID people who inject drugs, CKD chronic kidney diseases, CVD cardiovascular diseases, TB tuberculosis, ECG electrocardiogram, HBV/HCV hepatitis B/C virus